5 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors

3. Acceleron Pharma Inc. (NASDAQ:XLRN)

Holocene Advisors’ Stake Value: $128.5 million

Percentage of Holocene Advisors’ 13F Portfolio: 0.69%

Number of Hedge Fund Holders: 58

Acceleron Pharma Inc. (NASDAQ:XLRN) is another pharmaceutical company based in Massachusetts, US. The company is primarily focused on the development of drugs that regulate specific proteins involved in repairing cell and tissue damage. Its stock is prominent in the list of 10 pharmaceutical stocks to buy according to Brandon Haley’s Holocene Advisors. Holocene Advisors owns over 0.7 million shares in the company. They however, decreased their stake by 15% in the third quarter of 2021.

On November 22, Merck & Co., Inc. (NYSE:MRK) announced the successful acquisition of Acceleron Pharma Inc. (NASDAQ:XLRN).